Please read and agree to the
terms and conditions
of this site.
I agree
Funding Series
/tech
Clear filters and search
Format
photo
Tags
amgen
3
×
biotech
bristol-myers squibb
life sciences
national blog main
akero therapeutics
boston blog main
clinical trials
fda
fibroblast growth factor 21
gilead sciences
investing
madrigal pharmaceuticals
nonalcoholic steatohepatitis
venture capital
89bio
american society of clinical oncology
apple tree partners
asco
atlas venture
boston
boston top stories
cancer
deals
drugs
fatty liver disease
immunotherapy
intercept pharmaceuticals
jp morgan healthcare conference
longitude capital
lung cancer
metabolic diseases
metabolic disorders
mirati therapeutics
national institute of diabetes and digestive and kidney diseases
new york blog main
new york top stories
oncology
orbimed us
oribmed israel
What
drug
3
×
funding
advance
liver
million
nash
nonalcoholic
phase
steatohepatitis
therapeutics
akero
amgen
based
bio
biotech
cambridge
cancer
chase
clinical
closes
competition
debuted
develop
development
disease
disorder
fatty
financing
joins
launched
lead
licensed
mirati
monday
nasdaq
new
offering
plans
player
public
Language
Current search:
amgen
×
drug
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}